Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

606 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer.
Graefen M, Karakiewicz PI, Cagiannos I, Klein E, Kupelian PA, Quinn DI, Henshall SM, Grygiel JJ, Sutherland RL, Stricker PD, de Kernion J, Cangiano T, Schröder FH, Wildhagen MF, Scardino PT, Kattan MW. Graefen M, et al. Among authors: schroder fh. J Clin Oncol. 2002 Feb 15;20(4):951-6. doi: 10.1200/JCO.2002.20.4.951. J Clin Oncol. 2002. PMID: 11844816
International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy.
Graefen M, Karakiewicz PI, Cagiannos I, Quinn DI, Henshall SM, Grygiel JJ, Sutherland RL, Stricker PD, Klein E, Kupelian P, Skinner DG, Lieskovsky G, Bochner B, Huland H, Hammerer PG, Haese A, Erbersdobler A, Eastham JA, de Kernion J, Cangiano T, Schröder FH, Wildhagen MF, van der Kwast TH, Scardino PT, Kattan MW. Graefen M, et al. Among authors: schroder fh. J Clin Oncol. 2002 Aug 1;20(15):3206-12. doi: 10.1200/JCO.2002.12.019. J Clin Oncol. 2002. PMID: 12149292
Genetic evaluation of localized prostate cancer in a cohort of forty patients: gain of distal 8q discriminates between progressors and nonprogressors.
van Dekken H, Alers JC, Damen IA, Vissers KJ, Krijtenburg PJ, Hoedemaeker RF, Wildhagen MF, Hop WC, van der Kwast TH, Tanke HJ, Schröder FH. van Dekken H, et al. Among authors: schroder fh. Lab Invest. 2003 Jun;83(6):789-96. doi: 10.1097/01.lab.0000074889.76221.49. Lab Invest. 2003. PMID: 12808114 Free article.
Evaluation of genetic patterns in different tumor areas of intermediate-grade prostatic adenocarcinomas by high-resolution genomic array analysis.
van Dekken H, Paris PL, Albertson DG, Alers JC, Andaya A, Kowbel D, van der Kwast TH, Pinkel D, Schröder FH, Vissers KJ, Wildhagen MF, Collins C. van Dekken H, et al. Among authors: schroder fh. Genes Chromosomes Cancer. 2004 Mar;39(3):249-56. doi: 10.1002/gcc.20001. Genes Chromosomes Cancer. 2004. PMID: 14732926
Metastatic prostate cancer treated by flutamide versus cyproterone acetate. Final analysis of the "European Organization for Research and Treatment of Cancer" (EORTC) Protocol 30892.
Schröder FH, Whelan P, de Reijke TM, Kurth KH, Pavone-Macaluso M, Mattelaer J, van Velthoven RF, Debois M, Collette L; Members of the EORTC Genito-Urinary Group. Schröder FH, et al. Eur Urol. 2004 Apr;45(4):457-64. doi: 10.1016/j.eururo.2003.11.016. Eur Urol. 2004. PMID: 15041109 Clinical Trial.
606 results